KESTRA MEDICAL TECHNOLOGIES, LTD. Balance Sheet
KMTS / Health Care|3 years of annual SEC 10-K data (FY2023-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
KESTRA MEDICAL TECHNOLOGIES, LTD. had $296M in total assets and $205M in shareholders' equity as of FY2025. Total debt was $41M against $238M in cash, resulting in a $196M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.01 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash & Equivalents | $237.6M | $8.2M | - |
| Current Assets | $255.3M | $14.9M | - |
| PP&E (Net) | $34.8M | $26.1M | - |
| Total Assets | $295.7M | $45.9M | - |
| Current Liabilities | $38.0M | $33.0M | - |
| Total Debt | $41.1M | $42.5M | - |
| Shareholders' Equity | $205.4M | -$209.4M | -$117.6M |